Clinical trial
Clinical Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism-associated Fatty Liver Disease (MAFLD)
NCT06501326 is registered in ClinicalTrials.gov with Affiliated Hospital of Nantong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism-associated Fatty Liver Disease (MAFLD)
- Lead sponsor
- Affiliated Hospital of Nantong University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- November 1, 2023
- Completion date
- February 28, 2025
- Enrollment
- 102 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.